Quantcast

Latest ACell Inc. Stories

2014-03-31 08:30:30

New contract broadens access of MatriStem to an additional 100,000 healthcare entities COLUMBIA, Md., March 31, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has entered into a national purchasing agreement with Novation for the Company's MatriStem® devices. The MatriStem devices also were awarded the elite Innovative Technology...

2014-03-26 08:29:41

CME-credited Event to Leverage Broad UBM Clinical Experience for Expanded Awareness COLUMBIA, Md., March 26, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it will sponsor a continuing medical education (CME) credited lecture at the upcoming Academy of Physicians in Wound Healing (APWH) 2014 Annual Conference taking place March 27-30 in...

2014-02-10 08:27:05

Solution for deep, hard-to-heal wounds with additional contouring functionality COLUMBIA, Md., Feb. 10, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has launched the new MatriStem® Multilayer Wound Matrix device for deep, hard-to-heal, full-thickness wounds. The one-to-one (1:1) mesh design of MatriStem Multilayer Wound Matrix is built to...

2014-02-05 08:29:47

Offers broad range of regenerative therapy solutions COLUMBIA, Md., Feb. 5, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has expanded the MatriStem® Pelvic Floor Matrix product portfolio with the addition of four device sizes. The addition of four new sizes to the portfolio offers a broad range of viable solutions for physicians treating...

2014-01-13 08:29:02

COLUMBIA, Md., Jan. 13, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced it has initiated, with multiple patients enrolled, a U.S. post-market clinical trial (NCT01858545) comparing the efficacy of MatriStem® to a leading cellular scaffold, Dermagraft®, for the treatment of patients with diabetic foot ulcers (DFUs) that failed to adequately heal...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.